|
Topics in Evidence-Based Pharmacy Practice
12/30/2010: INVESTing In the Very Old
Stephanie Huizar
Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas
Tina Lopez
Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas
Excerpt:"Atherosclerotic coronary artery disease (CAD) is the most prevalent cardiac disease in the elderly.1 More than 80% of deaths are due to CAD in patients 65 years and older.1 By 2030, there will be approximately 72.1 million older persons living in the United States.2 We will see more patients at increased risk for cardiovascular (CV) events as the population continues to live longer. Although we are unable to control age, race, or gender, we can control several risk factors associated with CAD.1 Successful hypertension treatment decreases the risk for CV adverse events in young patient populations, but evidence is lacking for the elderly.3..."
|
|
|
|
|